166 related articles for article (PubMed ID: 30611960)
1. Total and acylated ghrelin plasma levels as potential long-term response markers in alcohol-dependent patients receiving high-dose of the GABA-B receptor agonist baclofen.
Geisel O; Hellweg R; Wernecke KD; Wiedemann K; Müller CA
Psychiatry Res; 2019 Feb; 272():431-437. PubMed ID: 30611960
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of brain-derived neurotrophic factor in alcohol-dependent patients receiving high-dose baclofen.
Geisel O; Hellweg R; Müller CA
Psychiatry Res; 2016 Jun; 240():177-180. PubMed ID: 27107672
[TBL] [Abstract][Full Text] [Related]
3. High-dose baclofen for the treatment of alcohol dependence (BACLAD study): a randomized, placebo-controlled trial.
Müller CA; Geisel O; Pelz P; Higl V; Krüger J; Stickel A; Beck A; Wernecke KD; Hellweg R; Heinz A
Eur Neuropsychopharmacol; 2015 Aug; 25(8):1167-77. PubMed ID: 26048580
[TBL] [Abstract][Full Text] [Related]
4. Neuroendocrine response to GABA-B receptor agonism in alcohol-dependent individuals: Results from a combined outpatient and human laboratory experiment.
Farokhnia M; Sheskier MB; Lee MR; Le AN; Singley E; Bouhlal S; Ton T; Zhao Z; Leggio L
Neuropharmacology; 2018 Jul; 137():230-239. PubMed ID: 29665351
[TBL] [Abstract][Full Text] [Related]
5. Effects of high-dose baclofen on cue reactivity in alcohol dependence: A randomized, placebo-controlled pharmaco-fMRI study.
Beck A; Pelz P; Lorenz RC; Charlet K; Geisel O; Heinz A; Wüstenberg T; Müller CA
Eur Neuropsychopharmacol; 2018 Nov; 28(11):1206-1216. PubMed ID: 30217552
[TBL] [Abstract][Full Text] [Related]
6. The safety and efficacy of baclofen to reduce alcohol use in veterans with chronic hepatitis C: a randomized controlled trial.
Hauser P; Fuller B; Ho SB; Thuras P; Kern S; Dieperink E
Addiction; 2017 Jul; 112(7):1173-1183. PubMed ID: 28192622
[TBL] [Abstract][Full Text] [Related]
7. Effect of High-Dose Baclofen on Agitation-Related Events Among Patients With Unhealthy Alcohol Use Receiving Mechanical Ventilation: A Randomized Clinical Trial.
Vourc'h M; Garret C; Gacouin A; Lacherade JC; Jonas M; Klouche K; Ferrandiere M; Jaber S; Flet L; Dailly E; Pouplet C; Maamar A; Reignier J; Roquilly A; Feuillet F; Mahe PJ; Asehnoune K;
JAMA; 2021 Feb; 325(8):732-741. PubMed ID: 33620407
[TBL] [Abstract][Full Text] [Related]
8. Hypothalamic-Pituitary-Adrenocortical Axis Activity in Alcohol-Dependent Patients During Treatment with High-Dose Baclofen.
Geisel O; Schlemm L; Hellweg R; Wiedemann K; Müller CA
Pharmacopsychiatry; 2019 Jan; 52(1):32-37. PubMed ID: 29359279
[TBL] [Abstract][Full Text] [Related]
9. Baclofen and severe alcohol dependence: an uncertain harm-benefit balance as of early 2013.
Prescrire Int; 2013 Sep; 22(141):214-7. PubMed ID: 24171218
[TBL] [Abstract][Full Text] [Related]
10. High-dose baclofen for treatment-resistant alcohol dependence.
Pastor A; Jones DM; Currie J
J Clin Psychopharmacol; 2012 Apr; 32(2):266-8. PubMed ID: 22367662
[TBL] [Abstract][Full Text] [Related]
11. Baclofen as add-on to standard psychosocial treatment for alcohol dependence: a randomized, double-blind, placebo-controlled trial with 1 year follow-up.
Ponizovsky AM; Rosca P; Aronovich E; Weizman A; Grinshpoon A
J Subst Abuse Treat; 2015 May; 52():24-30. PubMed ID: 25572706
[TBL] [Abstract][Full Text] [Related]
12. Moderation of baclofen response by a GABA
Morley KC; Luquin N; Baillie A; Fraser I; Trent RJ; Dore G; Phung N; Haber PS
Addiction; 2018 Dec; 113(12):2205-2213. PubMed ID: 29968397
[TBL] [Abstract][Full Text] [Related]
13. A Randomized, Placebo-Controlled Study of High-Dose Baclofen in Alcohol-Dependent Patients-The ALPADIR Study.
Reynaud M; Aubin HJ; Trinquet F; Zakine B; Dano C; Dematteis M; Trojak B; Paille F; Detilleux M
Alcohol Alcohol; 2017 Jul; 52(4):439-446. PubMed ID: 28525555
[TBL] [Abstract][Full Text] [Related]
14. Baclofen in the treatment of alcohol dependence with or without liver disease: multisite, randomised, double-blind, placebo-controlled trial.
Morley KC; Baillie A; Fraser I; Furneaux-Bate A; Dore G; Roberts M; Abdalla A; Phung N; Haber PS
Br J Psychiatry; 2018 Jun; 212(6):362-369. PubMed ID: 29716670
[TBL] [Abstract][Full Text] [Related]
15. Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study.
Addolorato G; Caputo F; Capristo E; Domenicali M; Bernardi M; Janiri L; Agabio R; Colombo G; Gessa GL; Gasbarrini G
Alcohol Alcohol; 2002; 37(5):504-8. PubMed ID: 12217947
[TBL] [Abstract][Full Text] [Related]
16. The efficacy and biobehavioural basis of baclofen in the treatment of alcoholic liver disease (BacALD): study protocol for a randomised controlled trial.
Morley KC; Leung S; Baillie A; Haber PS
Contemp Clin Trials; 2013 Nov; 36(2):348-55. PubMed ID: 23939511
[TBL] [Abstract][Full Text] [Related]
17. Titrated baclofen for high-risk alcohol consumption: a randomized placebo-controlled trial in out-patients with 1-year follow-up.
Rigal L; Sidorkiewicz S; Tréluyer JM; Perrodeau E; Le Jeunne C; Porcher R; Jaury P
Addiction; 2020 Jul; 115(7):1265-1276. PubMed ID: 31833590
[TBL] [Abstract][Full Text] [Related]
18. High-dose baclofen: withdrawal syndrome following abrupt discontinuation.
Prescrire Int; 2014 Oct; 23(153):241. PubMed ID: 25964972
[No Abstract] [Full Text] [Related]
19. Randomized open-label trial of baclofen for relapse prevention in alcohol dependence.
Gupta M; Verma P; Rastogi R; Arora S; Elwadhi D
Am J Drug Alcohol Abuse; 2017 May; 43(3):324-331. PubMed ID: 27808555
[TBL] [Abstract][Full Text] [Related]
20. Dose-response effect of baclofen in reducing daily alcohol intake in alcohol dependence: secondary analysis of a randomized, double-blind, placebo-controlled trial.
Addolorato G; Leggio L; Ferrulli A; Cardone S; Bedogni G; Caputo F; Gasbarrini G; Landolfi R;
Alcohol Alcohol; 2011; 46(3):312-7. PubMed ID: 21414953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
